Dermatology news & research- Page 5 of 12 | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Dermatology

Probiotics reduce risk of developing atopic eczema

Probiotics reduce risk of developing atopic eczema

Biologics most effective in treatment-resistant chronic spontaneous urticaria

Biologics most effective in treatment-resistant chronic spontaneous urticaria

EU approves bimekizumab for moderate to severe psoriasis

EU approves bimekizumab for moderate to severe psoriasis

Upadacitinib superior at clearing atopic eczema compared with dupilumab

Upadacitinib superior at clearing atopic eczema compared with dupilumab

Network meta-analysis confirms superiority of biologics to small molecules in plaque psoriasis

Network meta-analysis confirms superiority of biologics to small molecules in plaque psoriasis

Topical calcineurin inhibitor use associated with minimal increased risk of cancers

Topical calcineurin inhibitor use associated with minimal increased risk of cancers

Fumaric acid esters effective in children with moderate to severe psoriasis

Fumaric acid esters effective in children with moderate to severe psoriasis

Tele-health seen as time-efficient during COVID-19 according to those with skin conditions

Tele-health seen as time-efficient during COVID-19 according to those with skin conditions

Topical steroids normalise inflammatory markers in infants with atopic eczema

Topical steroids normalise inflammatory markers in infants with atopic eczema

Real-world data show that biologics for psoriasis are less effective in practice

Real-world data show that biologics for psoriasis are less effective in practice

Uncertainty over the efficacy of up-dosing antihistamine in chronic urticaria

Uncertainty over the efficacy of up-dosing antihistamine in chronic urticaria

Live-bacterial spray improves disease severity in children with atopic eczema

Live-bacterial spray improves disease severity in children with atopic eczema

Tape-stripping identifies a distinct biomarker to differentiate eczema from psoriasis

Tape-stripping identifies a distinct biomarker to differentiate eczema from psoriasis

Cosentyx® receives EU approval as first-line system for paediatric psoriasis

Cosentyx® receives EU approval as first-line system for paediatric psoriasis

Still no effective treatment for patients with CLE

Still no effective treatment for patients with CLE

JAK inhibitors: a major advance in the treatment of atopic eczema

JAK inhibitors: a major advance in the treatment of atopic eczema

Text message reminders have little impact on sun protection habits

Text message reminders have little impact on sun protection habits

IL-17 a potential therapeutic target in chronic urticaria

IL-17 a potential therapeutic target in chronic urticaria

x